Efficacy of Vitamin D on the Clinical Management of Pediatric Patients With Asthma
Status:
Unknown status
Trial end date:
2017-07-01
Target enrollment:
Participant gender:
Summary
Asthma is a disease that represents a public health problem worldwide, there are several
barriers, especially in pediatric patients with this disease, them, prevent the adequate
control of their condition, in addition every day there are new processing aids for this
entity; within these novel research we founded the relationship between decreased vitamin D
serum levels and his role in the regulating of the immune response, also this relationship in
the pathophysiology of this disease and responses in the event of infectious diseases of the
respiratory tract which can exacerbate symptoms in pediatric patients. We have been some of
clinical trials with the aim of improving serum levels of vitamin D in asthmatic patients,
however, these studies have different sources of bias and thus far there is no solid evidence
that favors or denies the relationship between asthma and vitamin D, this paper aims to help
generate this evidence to improve clinical management of these patients and their lung
function and increase the free time crisis.
In this trial two study groups which are divided for each of the interventions described
below:
Group low supplementation dose: 1 tablet of 400 IU was administered every 24 hours via oral,
regardless of time or if it is before or after food, preferably in the morning to improve
adherence to treatment, will be completed one year of treatment without suspension.
Group high supplementation dose: 1 tablet of 1600 IU should be administered every 24 hours
via oral, regardless of time or if it is before or after food, preferably in the morning to
improve adherence to treatment, will be completed one year of treatment without suspension
thereof.
Phase:
Phase 3
Details
Lead Sponsor:
Hospital General Naval de Alta Especialidad - Escuela Medico Naval
Treatments:
Cholecalciferol Ergocalciferols Vitamin D Vitamins